Tykerb N- {3-Chloro-4- [ (3-Fluorophenyl) -Methoxy] -Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} What is the main effect of -Quinazolin-4-Amine-Benzenesulfonic Acid
The drug is called Tykerb-related complex chemical expression, and the main effect of Tykerb is to fight cancer.
Tykerb is a small molecule tyrosine kinase inhibitor. In the field of breast cancer treatment, its role is crucial. The growth, proliferation and survival of breast cancer cells often depend on specific signaling pathways, among which the human epidermal growth factor receptor 2 (HER2) signaling pathway is particularly critical. Tykerb acts against HER2 and epidermal growth factor receptor (EGFR), blocking abnormal signaling in cancer cells by inhibiting the activity of related kinases. As a result, the growth and division of cancer cells are suppressed, and their survival ability is also weakened.
In clinical application, terisol is often used in combination with capecitabine for patients with HER2-positive advanced or metastatic breast cancer who have received previous treatment including anthracyclines, taxis and trastuzumab. It can effectively control tumor progression and prolong the progression-free survival and overall survival of patients. And terisol can cross the blood-brain barrier and has a certain therapeutic effect on breast cancer patients with brain metastasis, bringing hope to many breast cancer patients and improving their quality of life and prognosis.
Tykerb N- {3-Chloro-4- [ (3-Fluorophenyl) -Methoxy] -Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} What are the side effects of -Quinazolin-4-Amine-Benzenesulfonic Acid
Tykerb is lapatinib, and when used in combination with the complex chemicals described above, there may be various side effects.
This drug is used in the digestive system and often causes nausea and vomiting. As mentioned in "Lei Gong Pao Pharmaceutical Solution", the spleen and stomach bear the brunt of the drug entrance. This combination is easy to disturb the transportation of the spleen and stomach, and nausea occurs frequently. When the stomach qi is reversed, it will vomit. It can also cause diarrhea, intestinal conduction disorders, and the water and valley will not melt down.
On the skin, rashes are common. As described in "Authentic Surgical", the drug poison can cause skin rashes, redness and itching, and affect the appearance of the body.
The blood system is also affected, which can cause leukocytes and platelets to decrease. "Huangdi Nei Jing" says: "Zhongjiao is exposed to qi and juice, changes and redness, it is called blood". Drugs interfere with qi and blood biochemistry, involve bone marrow hematopoiesis, leukocytes and platelets are insufficient, and the body's defense and coagulation functions are affected.
Cardiac function may also be damaged, causing a decrease in cardiac function, frequent occurrence of palpitations and palpitations, and arrhythmia of cardiac pulsation. As discussed in the "Theory of the Sources of Disease", the heart controls the blood vessels, and the bias of drugs impairs the function of the heart.
In addition, there may be fatigue, headache and other discomforts, the whole body's qi and blood operation is disturbed, if the clear yang does not rise, it will cause headache, and if the righteousness is depleted, it will cause fatigue. Many side effects need to be carefully weighed by doctors in clinical practice, and strive to treat diseases and care for righteousness.
Tykerb N- {3-Chloro-4- [ (3-Fluorophenyl) -Methoxy] -Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} -Quinazolin-4-Amine-Benzenesulfonic How to use Acid
Tykerb (lapatinib) is a good anti-cancer drug. It is often used in combination with capecitabine to treat patients with advanced or metastatic breast cancer who have received prior treatment with anthracyclines, yew and trastuzumab for HER2 overexpression. In the question, "N- {3-Chloro-4- [ (3-Fluorophenyl) - Methoxy] - Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} - Quinazolin-4-Amine-Benzenesulfonic Acid" is a complex chemical name, or a related ingredient or variant of lapatinib.
Its usage is quite particular, and it is generally administered orally. The recommended dose is 1250mg, once a day, to be taken on an empty stomach (1 hour before or 2 hours after meals), and must not be chewed or crushed. If used in combination with capecitabine, the dose of capecitabine is 1000mg/m ², used twice a day for 14 consecutive days, with a rest of 7 days as a course of treatment. During the course of medication, be sure to strictly follow the doctor's advice, do not increase or decrease the dose at will, and pay close attention to your own reactions. If you feel unwell, inform the doctor immediately. During the medication period, regular follow-up examinations are also required so that the doctor can know the efficacy and physical condition of the medication, and adjust the medication plan in a timely manner to achieve the best therapeutic effect and ensure the well-being of the patient.
Tykerb N- {3-Chloro-4- [ (3-Fluorophenyl) -Methoxy] -Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} -Quinazolin-4-Amine-Benzenesulfonic Acid Who is suitable for
Tykerb (Tykerb) is lapatinib, and N- {3-chloro-4- [ (3-fluorophenyl) -methoxy] -phenyl} -6 - {5 - [ (2-methylsulfonylethyl) amino-methyl] -2 -furyl} -quinazoline-4-aminobenzenesulfonic acid This pharmaceutical composition is suitable for the following populations.
This drug is mostly used in breast cancer patients suffering from HER2 overexpression. In the past, medical records have recorded that the symptoms of breast cancer are common in women. If the HER2 protein is overexpressed in the body, and the cancer-causing cells proliferate rapidly and invasively, this drug may be a useful prescription. Due to the abnormal activation of the HER2 signaling pathway, it is crucial in the progression of such cancers, and drugs such as tekbub can target this pathway and inhibit the growth of cancer cells.
In addition, it is often considered for some patients with advanced or metastatic breast cancer who have previously received treatment including anthracyclines, yew and trastuzumab. Because the efficacy of conventional therapies for these patients is gradually diminishing and the disease is prolonged, this drug has a different approach and may bring about a turnaround. Through unique pharmacological mechanisms, it interferes with cancer cell signaling, delays the progression of the disease, and seeks survival for patients.
Tykerb N- {3-Chloro-4- [ (3-Fluorophenyl) -Methoxy] -Phenyl} -6- {5- { (2-Methylsulfonylethy Amino) -Methyl] -2-Furyl} Do -Quinazolin-4-Amine-Benzenesulfonic Acid interact with other drugs?
Can the drug Tykerb interact with other drugs called N- {3-chloro-4- [ (3-fluorophenyl) -methoxy] -phenyl} -6- {5- [ (2-methylsulfonyl ethylamino) -methyl] -2-furyl} -quinazoline-4-amine-benzenesulfonic acid?
The drug interaction is very complex. Although Tykerb has a unique pharmacology, when it enters the human body and is applied together with other drugs, it is still a river, and the waves of water and the urgency of flow can change the way.
If this drug is used with enzyme inducers, such as some anti-epileptic agents, the enzyme activity may increase, causing Tykerb to metabolize quickly, the blood drug concentration to drop, and the efficacy may not be caught. On the contrary, in the case of enzyme inhibitors, such as specific antibacterial drugs, the metabolism is blocked, the blood drug concentration or accumulation, and the risk of toxicity increases.
In addition, this drug has strong binding power with plasma proteins. If it encounters other drugs, it will also compete for the binding check point. The concentration of free drugs changes, and the efficacy and toxicity can be changed. As for cardiovascular and neurological drugs, when they are administered together, the physiological pathways are involved with each other, or they may cause changes in heart rhythm and hinder nerve conduction.
If you want to understand the details, you must follow rigorous clinical trials and pharmacological studies, and cannot make assumptions. When a doctor uses drugs, he should review the patient's physical condition and the nature of various drugs, weigh the advantages and disadvantages, and ensure that the drugs are effective and do not cause harm.